METTL3 is one of the most well-known m6A methyltransferases and is reported to contribute to the DDP resistance of bladder cancer, oral cancer, and seminoma through its methyltransferase activity (Wei et al., 2020; Qiao et al., 2021; Wei et al., 2021). Here, METTL3 is linked to lip and oral cavity carcinoma.